Deep-Sea Mining: Unveiling the Environmental Risks and Global Implications

Deep-Sea Mining: Unveiling the Environmental Risks and Global Implications

Deep-sea mining is gaining traction as the United States forges ahead with plans to exploit the ocean floor, particularly in international waters. This movement comes in the wake of an executive order signed by former President Trump aimed at boosting the U.S. Mining industry to diminish reliance on foreign sources, especially in light of China’s … Read more

Gene Therapy Shows Promise for Congenital Hearing Loss

Gene Therapy Shows Promise for Congenital Hearing Loss

A groundbreaking gene therapy is offering renewed hope for individuals with a rare form of congenital deafness, potentially transforming treatment options for those who previously relied on hearing aids or cochlear implants. Recent studies demonstrate that a single administration of this therapy can significantly improve auditory capabilities, even in adolescents and young adults up to … Read more

Saskatchewan Health Plan: Moe Aims for Primary Care Access & Reduced Wait Times by 2028

Saskatchewan Health Plan: Moe Aims for Primary Care Access & Reduced Wait Times by 2028

Saskatchewan’s newly unveiled “Patients First Health Care Plan” aims to tackle lengthy surgical wait times and improve access to primary care, but the strategy of increasing reliance on private clinics is already drawing criticism from health policy experts and labour unions. The plan, announced Monday, sets ambitious goals for 2028, including ensuring every resident has … Read more

Arexvy Approved for Adults 18-49 at Risk of RSV: GSK Announces Expansion

Arexvy Approved for Adults 18-49 at Risk of RSV: GSK Announces Expansion

In a significant development for public health, the U.S. Food and Drug Administration (FDA) has expanded the approved age indication for GSK’s Arexvy (Respiratory Syncytial Virus vaccine, adjuvanted) to include adults aged 18 to 49 years who are at increased risk for lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV). Previously, Arexvy … Read more